You are here: Industry Insights > Sun Pharma

News List

Sun Pharma recalls 13,000 bottles of chewable cetirizine in US financialexpress
June 01, 2017
The reason for the recall is failed tablet/capsule specifications: out of specification results for increased tablet hardness
FDA approves Sun Pharma’s tildrakizumab for moderate-to-severe plaque psoriasis pharmaceutical-technology
May 27, 2017
Indian company Sun Pharmaceutical Industries has received the US Food and Drug Administration (FDA) approval of the Biologics License Application (BLA) for tildrakizumab to treat patients with moderate-to-severe plaque psoriasis.
Sun Pharma Science Foundation recognises Indian scientists and young research scholars financialexpress
May 02, 2017
Science Award winners announced for exemplary contribution and research in pharma and medical science
Sun Pharma receives 11 observations from US FDA for Dadra plant financialexpress
April 24, 2017
The news has caused Sun Pharma’s stock to fall as much as three per cent
Sun Pharma: Sun Pharma resets goals, to focus on quality firstwordpharma
February 27, 2017
Dilip Shanghvi, managing director of Sun Pharmaceuticals, which has faced recent scrutiny from the FDA over issues at its plants, said he is trying to streamline quality-control processes that were overtaken by the merger with Ranbaxy, reported The Econom
Sun Pharma opens first production unit in Egypt financialexpress
February 22, 2017
The production unit worth $12.5 million was inaugurated by Indian Ambassador to Egypt Sanjay Bhattacharyya
Sun Pharma posts Rs 7,683 crs sales in Q3FY17 financialexpress
February 15, 2017
Registers a net profit of Rs 1,472 crores
Sun Pharma announces positive topline results of Phase-3 clinical trial for Seciera pharmaasia
January 19, 2017
Seciera meets primary and key secondary endpoints in pivotal trial, and shows efficacy at 12 weeks of treatment.

Previous page 1 2 3 4 5 6 7 8 9 Next page